Clinical trials: Vitreoretinal Detachment
Vitreoretinal Traction Syndrome
A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)
Plasmin is expected to create a posterior vitreous detachment (PVD) when injected directly into the eye. The pharmacological creation of a PVD may be beneficial in helping to treat a variety of conditions.
- Trial name
- NCT00347646
- Testing
- Plasmin
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Bausch & Lomb Incorporated
Epiretinal Membrane, Macular Hole
UNITY VCS Vitreoretinal Surgery
This purpose of this study is to compare the safety and effectiveness of two eye surgery systems-UNITY VCS and CONSTELLATION-in treating adults with vitreoretinal diseases or disorders.
- Conditions
- Epiretinal Membrane, Macular Hole, Visually Significant Vitreous Floater, Vitreomacular Traction
- Trial name
- NCT07054281
- Testing
- UNITY Vitreoretinal Cataract System (VCS), CONSTELLATION Vision System, Vitreoretinal ophthalmic surgery
- Where
- 8 sites in United States
- Sponsor
- Alcon Research
Vitreoretinal Traction Syndrome
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.
- Trial name
- NCT00348439
- Testing
- Plasmin, Vehicle
- Where
- United States
- Volunteers
- 29 people
- Sponsor
- Bausch & Lomb Incorporated